|
|
Volumn 103, Issue 5, 2011, Pages 364-366
|
|
Hints that statins reduce colon cancer risk finally being put to the test.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
HMGCR PROTEIN, HUMAN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
ANIMAL;
BLOOD;
COLON TUMOR;
GENETIC VARIABILITY;
GENETICS;
HUMAN;
NOTE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RISK;
TREATMENT FAILURE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CHOLESTEROL, LDL;
COLONIC NEOPLASMS;
GENETIC VARIATION;
HUMANS;
HYDROXYMETHYLGLUTARYL COA REDUCTASES;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK;
TREATMENT FAILURE;
|
|
EID: 79954521576
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djr057 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
